华康生物医学委任擎天资本为独立财务顾问

Core Viewpoint - Huakang Biomedical (08622) has appointed Qingtian Capital Limited as an independent financial advisor to provide advice on the offer and acceptance situation to the independent board committee, offer shareholders, and option holders [1] Group 1 - Qingtian Capital Limited has been granted a license to conduct regulated activities under the Securities and Futures Ordinance (Cap. 571) in Hong Kong [1] - The appointment of Qingtian Capital Limited was approved by the independent board committee in accordance with Rule 2.1 of the Takeovers Code [1]